Organon & Co To Go Ex-Dividend On May 10th, 2024 With 0.28 USD Dividend Per Share

May 3rd - $Organon & Co(OGN.US)$ is trading ex-dividend on May 10th, 2024. Shareholders of record on May 13th, 2024 will receive 0.28 USD dividend per share on June 13th, 2024. The ex-dividend dat

moomoo News19:40 ET

Amgen Stock Rallies 13% on Weight-loss Drug Updates, Tweaked Guidanace

Seeking Alpha17:40 ET

Viatris to Participate in the BofA Securities 2024 Health Care Conference

Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the company will participate in the BofA Securities 2024 Health Care...

PR Newswire17:00 ET

Pfizer Options Spot-On: On May 2nd, 345.72K Contracts Were Traded, With 3.32 Million Open Interest

On May 2nd ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 345.72K options for the day, of which put options accounted for 46.28% of the total transactions, and call op

moomoo News16:30 ET

Analysts Conflicted on These Healthcare Names: InMode (INMD) and Pfizer (PFE)

TipRanks16:10 ET

Janux Therapeutics Gains Amid Renewed Takeover Speculation

Seeking Alpha16:09 ET

Market Chatter: Novo Nordisk, Eli Lilly's Weight-Loss Drugs Get Price Cuts in UK

Novo Nordisk's (NVO) Wegovy and Eli Lilly's (LLY) Mounjaro had their prices lowered by British online pharmacies and slimming clinics as supply shortages ease after the drugs' recent launch, Reuters r

MT Newswires16:08 ET

Weigh Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy and Mounjaro

Online pharmacies and slimming clinics in Britain are reducing prices for Novo Nordisk A/S's (NYSE:NVO) Wegovy and Eli Lilly And Co (NYSE:LLY) Mounjaro as initial supply shortages ease, a move driven

Benzinga16:01 ET

Express News | NYSE Order Imbalance 176510.0 Shares on Sell Side

Reuters15:50 ET

Express News | NYSE Order Imbalance 100358.0 Shares on Buy Side

Reuters15:50 ET

Express News | NYSE Order Imbalance 431988.0 Shares on Sell Side

Reuters15:50 ET

AM Best Affirms Credit Ratings of Blue Whale Re Ltd.

AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of "a+" (Excellent) of Blue Whale Re Ltd. (Blue Whale) (Burlington, VT). The outlook of these Credit Ratings

Businesswire15:33 ET

Pfizer Prospects Garner Mixed Sentiment From Analysts: 'Finally, The Pivot Investors Have Been Waiting For'

Pfizer Inc (NYSE:PFE) reported first-quarter earnings Wednesday with adjusted EPS of 82 cents. That's down 33% year-over-year, beating the consensus of 54 cents.The New York-based company witnessed a

Benzinga15:15 ET

Palatin Spikes as FDA Clears Mid-stage Trial for Weight Loss Therapy

Seeking Alpha15:10 ET

Earnings Season: 3 Companies Boosting Guidance

Yahoo Finance14:59 ET

Radiopharma Stocks Higher as Sector Welcomes the Latest M&A Deal

Seeking Alpha14:31 ET

Organon Beats On Q1, Women's Health Leads the Charge

Organon & Co (NYSE:OGN) reported a 5% Y/Y increase in the first quarter of 2024 revenue, reaching around $1.622 billion, beating the consensus of $1.563 billion.Women's Health revenue increased by 11%

Benzinga13:58 ET

10 Health Care Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan

Benzinga13:35 ET

Pfizer Is Maintained at Equal-Weight by Morgan Stanley

Pfizer Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones13:23 ET

Express News | Morgan Stanley Maintains Equal-Weight on Pfizer, Raises Price Target to $29

Benzinga13:12 ET